TP53 and adenocarcinoma: TP53 was the most prevalent driver mutation (58.1% of cases; Extended Data Fig. 5d) and was found enriched in LCINS squamous cell carcinomas compared to adenocarcinomas, along with mutations in LRP1B, PIK3CA, and PTEN (Extended Data Fig. 6b–g).